Εμφάνιση απλής εγγραφής

dc.creatorThomas K., Lazarini A., Kaltsonoudis E., Drosos A., Papalopoulos I., Sidiropoulos P., Katsimbri P., Boumpas D., Tsatsani P., Gazi S., Fragkiadaki K., Tektonidou M., Sfikakis P.P., Pantazi L., Boki K.A., Grika E.P., Vlachoyiannopoulos P.G., Karagianni K., Sakkas L.I., Dimitroulas T., Garyfallos A., Kassimos D., Evangelatos G., Iliopoulos A., Areti M., Georganas C., Melissaropoulos K., Georgiou P., Vounotrypidis P., Ntelis K., Mavragani C.P., Bournazos I., Katsifis G., Mavrommatis C., Kitas G.D., Vassilopoulos D.en
dc.date.accessioned2023-01-31T10:08:26Z
dc.date.available2023-01-31T10:08:26Z
dc.date.issued2018
dc.identifier10.31138/mjr.29.1.27
dc.identifier.issn24593516
dc.identifier.urihttp://hdl.handle.net/11615/79705
dc.description.abstractAim of the study: To evaluate the current disease characteristics, treatment and comorbidities of rheumatoid arthritis (RA) in Greece. Methods: Multicenter, cross-sectional study with a 9-month recruitment period between 2015 and 2016. Demographics, disease characteristics, treatment and comorbidities were collected via a web-based platform. Results:2.491 RA patients were recruited: 96% from tertiary referral centers, 79% were females with a mean age of 63.1 years and disease duration of 9.9 years. Fifty-two percent were rheumatoid factor and/or anti-CCP positive, while 41% had erosive disease. Regarding treatment, 82% were on conventional synthetic disease modifying anti-rheumatic drugs (csDMARDs), 42% on biologic DMARDs (TNFi: 22%, non-TNFi: 20%) and 40% on corticosteroids (mean daily dose: 5.2 mg). Despite therapy, 36% of patients had moderate and 12% high disease activity. The most frequent comorbidities were hypertension (42%), hyperlipidemia (33%), osteoporosis (29%), diabetes mellitus (15%) and depression (12%). Latent tuberculosis infection (positive tuberculin skin test or interferon gamma release assay) was diagnosed in 13 and 15.3% of patients, respectively. Regarding chronic viral infections, 6.2% had history of herpes zoster while 2% and 0.7% had chronic hepatitis B and C virus infection, respectively. A history of serious infection was documented in 9.6%. Only 36% and 52% of the participants had ever been vaccinated against pneumococcus and influenza virus, respectively. Conclusion: This is one of the largest epidemiologic studies providing valuable data regarding the current RA characteristics in Greece. Half of patients were seropositive but despite therapy, half displayed residual disease activity, while preventive vaccination was limited. © Thomas K, Lazarini A, Kaltsonoudis E, Drosos AA, Papalopoulos I, Sidiropoulos P, Katsimbri P, Boumpas D, Tsatsani P, Gazi S, Fragkiadaki K, Tektonidou M, Sfikakis P P, Pantazi L, Boki K A, Grika E P, Vlachoyiannopoulos P G, Karagianni K, Sakkas L I, Dimitroulas T, Garyfallos A, Kassimos D, Gerasimos E, Iliopoulos A, Areti A, Georganas C, Melissaropoulos K, Georgiou P, Vounotrypidis P, Ntelis K, Mavragani C P, Bournazos I, Katsifis G, Mavrommatis C, Kitas G D, Vassilopoulos D.en
dc.language.isoenen
dc.sourceMediterranean Journal of Rheumatologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85085377516&doi=10.31138%2fmjr.29.1.27&partnerID=40&md5=a1abf83224043825829891215a829eca
dc.subjectanalgesic agenten
dc.subjectdisease modifying antirheumatic drugen
dc.subjectrheumatoid factoren
dc.subjecttumor necrosis factor inhibitoren
dc.subjectadulten
dc.subjectArticleen
dc.subjectchronic hepatitis Ben
dc.subjectchronic hepatitis Cen
dc.subjectclinical evaluationen
dc.subjectclinical featureen
dc.subjectcohort analysisen
dc.subjectcomorbidity assessmenten
dc.subjectcross-sectional studyen
dc.subjectdepressionen
dc.subjectdiabetes mellitusen
dc.subjectdisease activityen
dc.subjectdisease durationen
dc.subjectfemaleen
dc.subjectGreeceen
dc.subjectherpes zosteren
dc.subjecthumanen
dc.subjecthyperlipidemiaen
dc.subjecthypertensionen
dc.subjectinterferon gamma release assayen
dc.subjectlung tuberculosisen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmiddle ageden
dc.subjectmulticenter studyen
dc.subjectosteoporosisen
dc.subjectParainfluenza virus infectionen
dc.subjectphase 1 clinical trialen
dc.subjectphase 2 clinical trialen
dc.subjectphase 3 clinical trialen
dc.subjectpneumococcal infectionen
dc.subjectprospective studyen
dc.subjectrheumatoid arthritisen
dc.subjecttertiary care centeren
dc.subjecttreatment durationen
dc.subjecttreatment outcomeen
dc.subjecttuberculin testen
dc.subjectvaccination coverageen
dc.subjectvirus infectionen
dc.subjectGreek Rheumatology Society and Professional Association of Rheumatologistsen
dc.titleMulticenter cross-sectional study of patients with rheumatoid arthritis in Greece: Results from a cohort of 2.491 patientsen
dc.typejournalArticleen


Αρχεία σε αυτό το τεκμήριο

ΑρχείαΜέγεθοςΤύποςΠροβολή

Δεν υπάρχουν αρχεία που να σχετίζονται με αυτό το τεκμήριο.

Αυτό το τεκμήριο εμφανίζεται στις ακόλουθες συλλογές

Εμφάνιση απλής εγγραφής